CHENGDU, China (Reuters) – China’s will likely have produced 3 billion doses of COVID-19 vaccines by the end of the year, a National Health Commission official said on Saturday. Zheng Zhongwei, who …
Monthly Archives For April 2021
China’s COVID-19 vaccine output could exceed 3 billion by year-end – official
China’s output of COVID-19 vaccines could reach more than 3 billion doses by the end of 2021, a National Health Commission official said on Saturday. Zheng Zhongwei, who also heads a team coordinating …
Events Leading up to China’s $2.75 Billion Fine on Alibaba
Events Leading up to China’s $2.75 Billion Fine on Alibaba The Alibaba business empire has come under intense scrutiny in China since its billionaire founder Jack Ma’s stinging public criticism of the …
Alibaba Group Has Received the Administrative Penalty Decision Issued by the State Administration for Market Regulation of the People’s Republic of China
800 820 2079 China Mobile: 400 820 6895 Conference ID: 6934098 (English) A live webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/t76yro7p. An archived webcast will …
ZTE Secures China Mobile’s New SPN Centralized Procurement
ZTE Corporation has announced that it has secured the largest share in China’s 11 provinces in China Mobile’s bidding of new SPN project centralized procurement 2021-2022, and been selected in all 26 …
China’s Sinopharm, Sinovac COVID-19 vaccines in final stages of evaluation: WHO
China’s Sinopharm, Sinovac COVID-19 vaccines are in the final stages of evaluation, said the World Health Organization (WHO). The two Chinese vaccines, once approved, will be used under the WHO’s …
China Fines Alibaba Record $2.8 Billion After Monopoly Probe
China imposed a record fine of 18.2 billion yuan ($2.8 billion) on Alibaba Group Holding Ltd. after an anti-monopoly probe found that it had abused its dominant market position.The penalty is triple …
China’s Didi prepares for IPO in US, sources say
BEIJING — Didi Chuxing, China’s top ride-hailing company, is preparing an IPO in the U.S., Nikkei has learned. The IPO is expected to value the company at around $70 billion to $100 billion.
Sinopharm’s protein-based COVID-19 vaccine candidate gets China clinical trial nod
BEIJING, April 10 (Reuters) – The China National Biotec Group Company (CNBG) has obtained regulatory approval to move a third COVID-19 vaccine candidate into the human testing stage in China, CNBG …
China opposes addition of 7 companies to US export-control list: MOC
China is opposed to the United States including seven Chinese supercomputing entities in its “entity list” for export controls, a Ministry of Commerce spokesperson said Friday. Employing excuses such …
Top 10 IPOs by China’s billion-dollar tech start-ups to watch for in 2021, including Megvii, Douyin, Didi Chuxing and ByteDance
it would simply stop the IPO of any “sick” company trying to force its way through to IPO in Shanghai or Shenzhen. China’s booming consumer market is good fodder for unicorns that specialise in …
Alibaba fined $2.8 billion on competition charge in China
Party leaders worry about the dominance of China’s biggest internet companies, which are expanding into finance, health services and other sensitive areas. The party says anti-monopoly enforcement, …
China fines Alibaba billions for alleged market abuses
Platform co-founded by Jack Ma, who has criticised Chinese authorities, misused its dominance, say state regulators …
